Valneva SE INRLF
2.49 USD 0.00 (+0.00%)
At closeNov 4, 2026, 4:00 PM EST
3.00 Day range 3.00
2.43 52-week range 5.90
- YTD
- -40.71%
- 1 year
- -45.87%
- Market cap
- 473.74M
- EPS (ttm)
- -1.05
- YTD return
- -40.71%
- 1-year return
- -45.87%
- Volume
- 602
- Avg volume
- 29
- Open
- 3.00
- Previous close
- 2.49
- Day's range
- 3.00 – 3.00
- 52-week range
- 2.43 – 5.90
2Y -0.27 (-9.78%)
News
Valneva SE (VALN) Q1 2026 Earnings Call Transcript 
VALNEVA: Declaration of shares and voting rights - Status as of April 30, 2026 taking into account interim information as at May 5, 2026 
Declaration of shares and voting rights of Valneva SE – March 2026 
An experimental Lyme disease vaccine from Pfizer and Valneva was effective at preventing the tick-borne disease in a new clinical trial but the findings aren't conclusive 
Valneva-Pfizer Lyme Shot Stumbles Yet Keeps Regulatory Path Alive 
Pfizer, Valneva Report Strong Efficacy Data From Lyme Vaccine Trial 
Pfizer-Valneva Lyme disease shot shows more than 70% efficacy in late-stage trial 
Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial 
Valneva SE (VALN) Q4 2025 Earnings Call Transcript 
VALNEVA Declaration of shares and voting rights: February 28, 2026
Your note
Sign in to keep a note on INRLF — it syncs with the Stock Master app.